UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 10-Q
x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2004
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
Commission file number: 001-14057
KINDRED HEALTHCARE, INC.
(Exact name of registrant as specified in its charter)
| Delaware | 61-1323993 | |
| (State or other jurisdiction of | (I.R.S. Employer | |
| incorporation or organization) | Identification No.) | |
| 680 South Fourth Street | ||
| Louisville, KY | 40202-2412 | |
| (Address of principal executive offices) | (Zip Code) | |
(502) 596-7300
(Registrants telephone number, including area code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨
Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act.) Yes x No ¨
Indicate by check mark whether the registrant has filed all documents and reports required to be filed by Sections 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court. Yes x No ¨
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
| Class of Common Stock |
Outstanding at April 30, 2004 | |
| Common stock, $0.25 par value | 18,189,328 shares |
1 of 39
FORM 10-Q
INDEX
| Page | ||||
| PART I. | FINANCIAL INFORMATION | |||
| Item 1. | Financial Statements: |
|||
|
Condensed Consolidated Statement of Operations for the three months |
3 | |||
| Condensed Consolidated Balance Sheet March 31, 2004 and December 31, 2003 |
4 | |||
|
Condensed Consolidated Statement of Cash Flows for the three months |
5 | |||
| 6 | ||||
| Item 2. | Managements Discussion and Analysis of Financial Condition and Results of Operations |
19 | ||
| Item 3. | 34 | |||
| Item 4. | 34 | |||
| PART II. | OTHER INFORMATION | |||
| Item 1. | 36 | |||
| Item 6. | 38 | |||
2
CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS
(Unaudited)
(In thousands, except per share amounts)
| Three months ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Revenues |
$ | 871,262 | $ | 802,158 | ||||
| Salaries, wages and benefits |
492,071 | 460,752 | ||||||
| Supplies |
116,733 | 104,182 | ||||||
| Rent |
64,459 | 63,078 | ||||||
| Other operating expenses |
145,406 | 146,839 | ||||||
| Depreciation |
22,046 | 19,195 | ||||||
| Interest expense |
3,656 | 2,888 | ||||||
| Investment income |
(1,218 | ) | (1,635 | ) | ||||
| 843,153 | 795,299 | |||||||
| Income from continuing operations before income taxes |
28,109 | 6,859 | ||||||
| Provision for income taxes |
11,834 | 4,348 | ||||||
| Income from continuing operations |
16,275 | 2,511 | ||||||
| Loss from discontinued operations, net of income taxes |
(2,435 | ) | (15,635 | ) | ||||
| Net income (loss) |
$ | 13,840 | $ | (13,124 | ) | |||
| Earnings (loss) per common share: |
||||||||
| Basic: |
||||||||
| Income from continuing operations |
$ | 0.46 | $ | 0.07 | ||||
| Loss from discontinued operations |
(0.07 | ) | (0.45 | ) | ||||
| Net income (loss) |
$ | 0.39 | $ | (0.38 | ) | |||
| Diluted: |
||||||||
| Income from continuing operations |
$ | 0.38 | $ | 0.07 | ||||
| Loss from discontinued operations |
(0.06 | ) | (0.45 | ) | ||||
| Net income (loss) |
$ | 0.32 | $ | (0.38 | ) | |||
| Shares used in computing earnings (loss) per common share: |
||||||||
| Basic |
35,414 | 34,755 | ||||||
| Diluted |
42,721 | 34,767 | ||||||
See accompanying notes.
3
CONDENSED CONSOLIDATED BALANCE SHEET
(Unaudited)
(In thousands, except per share amounts)
| March 31, 2004 |
December 31, 2003 |
|||||||
| ASSETS | ||||||||
| Current assets: |
||||||||
| Cash and cash equivalents |
$ | 17,827 | $ | 66,524 | ||||
| Cash restricted |
7,864 | 7,339 | ||||||
| Insurance subsidiary investments |
175,710 | 146,325 | ||||||
| Accounts receivable less allowance for loss of $94,160 March 31 and |
475,238 | 429,304 | ||||||
| Inventories |
31,135 | 29,984 | ||||||
| Deferred tax assets |
89,836 | 89,836 | ||||||
| Assets held for sale |
27,360 | 27,400 | ||||||
| Other |
54,455 | 46,375 | ||||||
| 879,425 | 843,087 | |||||||
| Property and equipment |
688,959 | 671,850 | ||||||
| Accumulated depreciation |
(212,963 | ) | (193,310 | ) | ||||
| 475,996 | 478,540 | |||||||
| Goodwill |
31,417 | 31,417 | ||||||
| Insurance subsidiary investments |
66,157 | 74,618 | ||||||
| Deferred tax assets |
91,991 | 92,093 | ||||||
| Other |
63,066 | 65,659 | ||||||
| $ | 1,608,052 | $ | 1,585,414 | |||||
| LIABILITIES AND STOCKHOLDERS EQUITY | ||||||||
| Current liabilities: |
||||||||
| Accounts payable |
$ | 119,057 | $ | 119,087 | ||||
| Salaries, wages and other compensation |
207,004 | 214,113 | ||||||
| Due to third party payors |
27,669 | 31,406 | ||||||
| Professional liability risks |
71,140 | 83,725 | ||||||
| Other accrued liabilities |
83,938 | 88,333 | ||||||
| Income taxes |
46,356 | 36,684 | ||||||
| Long-term debt due within one year |
4,729 | 4,532 | ||||||
| 559,893 | 577,880 | |||||||
| Long-term debt |
154,708 | 139,397 | ||||||
| Professional liability risks |
220,714 | 212,013 | ||||||
| Deferred credits and other liabilities |
58,974 | 58,559 | ||||||
| Commitments and contingencies |
||||||||
| Stockholders equity: |
||||||||
| Common stock, $0.25 par value; authorized 175,000 shares; issued 36,369 shares March 31 and 36,340 shares December 31 |
9,092 | 9,085 | ||||||
| Capital in excess of par value |
585,853 | 585,394 | ||||||
| Deferred compensation |
(6,296 | ) | (8,040 | ) | ||||
| Accumulated other comprehensive income |
496 | 348 | ||||||
| Retained earnings |
24,618 | 10,778 | ||||||
| 613,763 | 597,565 | |||||||
| $ | 1,608,052 | $ | 1,585,414 | |||||
See accompanying notes.
4
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS
(Unaudited)
(In thousands)
| Three months ended March 31, |
||||||||
| 2004 |
2003 |
|||||||
| Cash flows from operating activities: |
||||||||
| Net income (loss) |
$ | 13,840 | $ | (13,124 | ) | |||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
||||||||
| Depreciation |
22,046 | 20,083 | ||||||
| Amortization of deferred compensation costs |
1,743 | 1,253 | ||||||
| Provision for doubtful accounts |
8,116 | 6,288 | ||||||
| Other |
(102 | ) | 506 | |||||
| Change in operating assets and liabilities: |
||||||||
| Accounts receivable |
(54,304 | ) | (53,316 | ) | ||||
| Inventories and other assets |
(9,468 | ) | (6,387 | ) | ||||
| Accounts payable |
(3,184 | ) | (2,998 | ) | ||||
| Income taxes |
9,912 | (5,457 | ) | |||||
| Due to third party payors |
(3,737 | ) | 3,551 | |||||
| Other accrued liabilities |
(9,062 | ) | 27,935 | |||||
| Net cash used in operating activities |
(24,200 | ) | (21,666 | ) | ||||
| Cash flows from investing activities: |
||||||||
| Purchase of property and equipment |
(17,881 | ) | (10,565 | ) | ||||
| Purchase of insurance subsidiary investments |
(9,776 | ) | (30,395 | ) | ||||
| Sale of insurance subsidiary investments |
5,672 | 2,333 | ||||||
| Net change in insurance subsidiary cash and cash equivalents |
(16,820 | ) | (71,911 | ) | ||||
| Net change in other investments |
1,777 | (4,685 | ) | |||||
| Other |
508 | (333 | ) | |||||
| Net cash used in investing activities |
(36,520 | ) | (115,556 | ) | ||||
| Cash flows from financing activities: |
||||||||
| Net change in revolving credit borrowings |
16,900 | | ||||||
| Repayment of long-term debt |
(1,032 | ) | (112 | ) | ||||
| Payment of deferred financing costs |
| (1,596 | ) | |||||
| Issuance of common stock |
467 | | ||||||
| Other |
(4,312 | ) | (4,967 | ) | ||||
| Net cash provided by (used in) financing activities |
12,023 | (6,675 | ) | |||||
| Change in cash and cash equivalents |
(48,697 | ) | (143,897 | ) | ||||
| Cash and cash equivalents at beginning of period |
66,524 | 244,070 | ||||||
| Cash and cash equivalents at end of period |
$ | 17,827 | $ | 100,173 | ||||
| Supplemental information: |
||||||||
| Interest payments |
$ | 3,272 | $ | 2,835 | ||||
| Income tax payments |
398 | 18 | ||||||
See accompanying notes.
5
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
NOTE 1 BASIS OF PRESENTATION
Business
Kindred Healthcare, Inc. (Kindred or the Company) is a healthcare services company that operates hospitals, nursing centers, institutional pharmacies and a contract rehabilitation services business. At March 31, 2004, the Companys hospital division operated 68 hospitals in 23 states. The Companys health services division operated 254 nursing centers in 30 states. The Companys pharmacy division operated an institutional pharmacy business with 30 pharmacies in 19 states. The Company also operated a contract rehabilitation services business which began operating as a separate division on January 1, 2004.
During 2003, the Company effected certain strategic transactions to improve its future operating results. These transactions included the divestiture of all of its Florida and Texas nursing center operations, the acquisition for resale of eight additional nursing centers and two hospitals formerly leased from Ventas, Inc. (Ventas) and certain other dispositions and contract terminations. For accounting purposes, the operating results of these businesses and the losses associated with these transactions have been classified as discontinued operations in the accompanying unaudited condensed consolidated statement of operations for all periods presented. Assets not sold at March 31, 2004 have been measured at the lower of carrying value or estimated fair value less costs of disposal and have been classified as held for sale in the accompanying unaudited condensed consolidated balance sheet. See Note 2 for a summary of discontinued operations.
On April 20, 2001, the Company and its subsidiaries emerged from proceedings under Chapter 11 of Title 11 of the United States Code (the Bankruptcy Code) pursuant to the terms of the Companys Fourth Amended Joint Plan of Reorganization (the Plan of Reorganization), as modified at the confirmation hearing by the United States Bankruptcy Court for the District of Delaware. In connection with its emergence, the Company changed its name to Kindred Healthcare, Inc.
Stock Split
On April 26, 2004, the Board of Directors declared a 2-for-1 stock split in the form of a 100% stock dividend. The new shares will be distributed on May 27, 2004 to stockholders of record at the close of business on May 10, 2004. Share and per share data for all periods presented in the accompanying unaudited condensed consolidated financial statements have been adjusted retroactively to reflect the stock split.
Impact of Recent Accounting Pronouncements
In January 2003, the Financial Accounting Standards Board (the FASB) issued FASB Interpretation No. 46 (FIN 46), Consolidation of Variable Interest Entities an interpretation of ARB No. 51. The primary objectives of FIN 46 are to provide guidance on the identification of entities for which control is achieved through means other than through voting rights (variable interest entities or VIEs) and how to determine when and which business enterprise should consolidate the VIE (the primary beneficiary). In December 2003, the FASB issued FIN 46-R (FIN 46-R), Consolidation of Variable Interest Entities an interpretation of ARB No. 51 (revised December 2003), which replaces FIN 46. FIN 46-R incorporates certain modifications to FIN 46 adopted by the FASB subsequent to the issuance of FIN 46, including modifications to the scope of FIN 46. Additionally, FIN 46-R also incorporates much of the guidance previously issued in the form of FASB Staff Positions. The Company has adopted all of the provisions of FIN 46-R in the first quarter of 2004. The adoption of FIN 46-R did not have an impact on the presentation of the Companys financial position, results of operations or liquidity.
6
KINDRED HEALTHCARE, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (Continued)
(Unaudited)
NOTE 1 BASIS OF PRESENTATION (Continued)
Stock Option Accounting
The Company follows Accounting Principles Board Opinion No. 25, Accounting for Stock Issued to Employees, and related interpretations in accounting for its stock options because the alternative fair value accounting provided for under Statement of Financial Accounting Standards (SFAS) No. 123 (SFAS 123), Accounting for Stock-Based Compensation, requires the use of option valuation models that were not developed for use in valuing stock options.
Pro forma information regarding net income and earnings per share determined as if the Company had accounted for its stock options under the fair value method of SFAS 123 follows (in thousands, except per share amounts):
| Thre | ||||||||